Cargando…
Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer
BACKGROUND: Superior sulcus tumours (SSTs) are relatively uncommon and one of the most intractable lung cancers among non-small cell lung cancer (NSCLC). We planned a multicenter, single-arm confirmatory trial of new multidisciplinary treatment using immune-checkpoint inhibitor. The aim is to evalua...
Autores principales: | Aokage, Keiju, Tsuboi, Masahiro, Zenke, Yoshitaka, Horinouchi, Hidehito, Nakamura, Naoki, Ishikura, Satoshi, Nishikawa, Hiroyoshi, Kumagai, Shogo, Koyama, Shohei, Kanato, Keisuke, Kataoka, Tomoko, Wakabayashi, Masashi, Fukutani, Miki, Fukuda, Haruhiko, Ohe, Yuichiro, Watanabe, Shun-ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985519/ https://www.ncbi.nlm.nih.gov/pubmed/34999817 http://dx.doi.org/10.1093/jjco/hyab208 |
Ejemplares similares
-
Acquired amegakaryocytic thrombocytopenia after durvalumab
administration
por: Suyama, Takahiro, et al.
Publicado: (2021) -
Durvalumab activity in previously treated patients who stopped durvalumab without disease progression
por: Sheth, Siddharth, et al.
Publicado: (2020) -
Durvalumab: First Global Approval
por: Syed, Yahiya Y.
Publicado: (2017) -
Retinal Vasculitis Secondary to Durvalumab
por: R. Andrade, Antonio, et al.
Publicado: (2020) -
Durvalumab-induced Severe Gastritis
por: Otohara, Masaya, et al.
Publicado: (2021)